Halil Ibrahim Ellez

6PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyMedical biochemistry - proteins and peptides (incl. medical proteomics)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices.

|May 21, 2026
Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

|May 04, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

|Sep 26, 2025
Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors.

Seyhmus Abakay, Hüseyin Döngelli, Nilay Danış

|Aug 30, 2024
Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis.

Halil Ibrahim Ellez, Nilay Danis, Ulus Salih Akarca

|Sep 09, 2023
The Prognostic Nutritional Index (PNI): A New Biomarker for Determining Prognosis in Metastatic Castration-Sensitive Prostate Carcinoma.

Halil Ibrahim Ellez, Merve Keskinkilic, Hüseyin Salih Semiz

Pageof 1

Frequent Collaborators

3 joint publications

Hüseyin Salih Semiz

2 joint publications

Nilay Danış

2 joint publications

Kubra Canaslan

1 joint publications

Mehmet Emin Arayici